Vanguard Portfolio Management
RDY icon

Vanguard Portfolio Management’s Dr. Reddy's Laboratories RDY Stock Holding History

Vanguard Portfolio Management’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22.1M Sell
1,522,361
-251,377
-14% -$3.39M ﹤0.01% 1957
2026
Q1 		$24.6M Buy
+1,773,738
New +$24.7M ﹤0.01% 1837

Other funds holding RDY

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
AIM
Aikya Investment Management London, United Kingdom $341M AUM 28.74% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Vanguard Portfolio Management's RDY Position: Q2 2026 in Review

Vanguard Portfolio Management reduced its Dr. Reddy's Laboratories (RDY) stake by 14% in Q2 2026, selling an estimated $3.39M and leaving 1,522,361 shares worth $22.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1957.

Vanguard Portfolio Management first reported a position in RDY in Q1 2026 and has held it in 2 quarters since. The position peaked at $24.6M in Q1 2026. 238 funds tracked by Wall St. Rank hold RDY as of Q2 2026.

  • Vanguard Portfolio Management held 1,522,361 shares of Dr. Reddy's Laboratories worth $22.1M as of Q2 2026.
  • Vanguard Portfolio Management sold 251,377 Dr. Reddy's Laboratories shares in Q2 2026, an estimated $3.39M.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Vanguard Portfolio Management's portfolio in Q2 2026, its #1957 holding.
  • Vanguard Portfolio Management first reported a position in Dr. Reddy's Laboratories in Q1 2026 and has held it in 2 quarters since.
  • Vanguard Portfolio Management's Dr. Reddy's Laboratories position peaked at $24.6M in Q1 2026.
  • 238 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q2 2026.

Based on Vanguard Portfolio Management's 13F filing for Q2 2026, filed 13 Aug 2026.